Laura works in CEPA’s global health sector. She has extensive experience particularly focussing on evaluations, strategic reviews, value for money analyses, and a variety of technical and organisational support to a wide range of global health organisations.
Laura Grobicki is a managing consultant in CEPA's Global Health practice. Her work has focused particularly on global heath evaluations, strategic reviews, value for money analyses, and the provision of technical and organisational support to global health organisations. Her areas of expertise include global health architecture, communicable diseases (HIV, tuberculosis, malaria), immunisation, non-communicable and epidemic diseases, as well as cross-cutting areas of health and community systems strengthening, universal health coverage, commodity market dynamics as well as access and supply of health commodities. Laura has undertaken work with the Global Fund, Gavi the Vaccine Alliance, Unitaid, WHO, the Medicines Patent Pool, the World Bank, Stop TB Partnership, UNDP, country governments and NGOs. Working alongside international organisations and country governments, her work has been used to inform policy in various regions.
Laura previously worked at University College London (UCL) in the Centre for Global Health Economics and at the Institute for Health Equity. Among other projects, Laura conducted HIV allocation efficiency analyses, epidemiological projections and financial commitment studies for countries in West and Central Africa and Eastern Europe and Central Asia for the World Bank.
Laura also has a sound understanding of health service delivery and organisation of care from her wide range of country level experience including Australia, Bulgaria, Cambodia, Ethiopia, Georgia, India, Kenya, Lesotho, Macedonia, Malawi, Nepal, South Africa, Togo, Uganda, United Kingdom; Zambia and Zimbabwe. In particular, she has worked as a healthcare professional in high and low-income settings and across both rural and urban areas. She holds a MSc in Global Health and Development from UCL and a BSc from Curtin University of Technology, Western Australia.
Recent News & insights
Unitaid molecular diagnostics portfolio review
CEPA was appointed by Unitaid to conduct a portfolio-level joint end-of-grant evaluation of its investments in Point of Care (POC) molecular diagnostics for HIV.
Gavi supply and procurement strategy evaluation
CEPA was appointed by Gavi to conduct an evaluation of the 2016-20 Supply and Procurement Strategy (their market shaping strategy). This large-scale evaluation involved an assessment of the design, implementation and results of the strategy.
TERG / Global Fund HIV primary prevention review
The Global Fund Technical Evaluation Reference Group (TERG) commissioned CEPA to conduct a review of the Global Fund’s investments in HIV primary prevention.
Evaluation of Unitaid Next Generation Indoor Residual Spray (NgenIRS) project
Unitaid commissioned CEPA to conduct an end of project evaluation of the NgenIRS project which aimed to facilitate the creation of a sustainable market for third-generation Indoor Residual Spraying (3GIRS) products.
Gavi eligibility and transition and co-financing policy evaluation
Evaluation of Gavi’s Eligibility and Transition and Co-financing Policies.
Applying the ‘no-one worse off’ criterion
Laura Grobicki has contributed to an article published in the journal 'AIDS', related to the HIV allocative efficiency modelling work she undertook in Togo.
Evaluation of cooperation agreements between health organisations
The Global Fund commissioned CEPA to conduct an evaluation of its Cooperation Agreements with WHO and the Stop TB Partnership on the provision of technical assistance to support the development of country concept notes and grant-making.
Thematic review to assess an approach to investing in resilient & sustainable systems for health
CEPA conducted a thematic review to assess the Global Fund’s current approach to investments in Resilient and Sustainable Systems for Health (RSSH).
Evaluation of community, human rights and gender interventions
CEPA was appointed to develop an evaluation framework and methodology to help the Stop TB Partnership to evaluate its community, human rights and gender focused work.